-
- Ishida Tomoaki
- Department of Pharmacy, Kochi Medical School Hospital
-
- Jobu Kohei
- Department of Pharmacy, Kochi Medical School Hospital
-
- Morisawa Shumpei
- Department of Pharmacy, Kochi Medical School Hospital Graduate School of Integrated Arts and Sciences, Kochi University
-
- Kawada Kei
- Department of Pharmacy, Kochi Medical School Hospital Graduate School of Integrated Arts and Sciences, Kochi University
-
- Yoshioka Saburo
- Graduate School of Integrated Arts and Sciences, Kochi University
-
- Miyamura Mitsuhiko
- Department of Pharmacy, Kochi Medical School Hospital Graduate School of Integrated Arts and Sciences, Kochi University
この論文をさがす
説明
<p>In obese patients with type 2 diabetes, reduced insulin sensitivity, increased production of inflammatory cytokines, and increased oxidative stress were observed, which lead to decreased protein synthesis and increased proteolysis in the skeletal muscles. Juzentaihoto (JTT) is herbal medicine and we have previously reported that the administration of JTT hot water extract alleviates skeletal muscle atrophy in a mouse model with streptozotocin-induced type 1 diabetes. In this study, we evaluated the inhibitory effects of JTT on muscle atrophy in a mouse model with obesity and type 2 diabetes. JTT was administered to KKAy mice with type 2 diabetic obesity and its effects on the skeletal muscles were evaluated. After JTT administration in KKAy mice, the wet weight and muscle fibre cross-sectional area of gastrocnemius increased and the time duration of exercise in the rotarod test improved. In addition, the serum levels of tumour necrosis factor-α and interleukin-6 decreased, adiponectin levels increased, and homeostasis model assessment for insulin resistance improved. Furthermore, JTT administration decreased the mRNA levels of ubiquitin ligase (atrogin-1, muscle RING-finger protein-1), increased the mRNA levels of Sirtuin1 in gastrocnemius. Our results suggest that JTT improves insulin resistance, suppresses inflammation, and reduces oxidative stress in KKAy mice, thereby suppressing skeletal muscle atrophy. JTT administration in clinical practice is expected to improve muscle atrophy in patients with obesity and type 2 diabetes.</p>
収録刊行物
-
- Ｂｉｏｌｏｇｉｃａｌ ＆ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｂｕｌｌｅｔｉｎ
-
Ｂｉｏｌｏｇｉｃａｌ ＆ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｂｕｌｌｅｔｉｎ 45 (7), 888-894, 2022-07-01
公益社団法人 日本薬学会